These evidence-based guidelines are developed and updated regularly by a committee of experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventative aspects of care.
AASLD provides access to the full text guideline PDFs for personal use. Summary versions are available for recent guidelines . Guideline development process [PDF]
The present version of the American Association for the Study of Liver Diseases (AASLD) Position Paper represents a thorough overhaul from the previous version of 2005. In addition to two new additional authors, the revision includes updated expert opinion regarding (1) etiologies and diagnosis, (2) therapies and intensive care management, and (3) prognosis and transplantation. We offer three publications:
Robert S. O’Shea, Srinivasan Dasarathy, Arthur J. McCullough, and the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology.
AASLD Guidelines for Treatment of Chronic Hepatitis B [Website View] [Download PDF]
Three systematic reviews that were commissioned to support the guideline were published in January 2016:
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis [Website View] [Download PDF]
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis [Website View] [Download PDF]
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis [Website View] [Download PDF]
HCV Guidance Published in HEPATOLOGY
Download: http://onlinelibrary.wiley.com/doi/10.1002/hep.27950/pdf [PDF]
AASLD/IDSA HCV Guidance Panel
Accepted manuscript online: 25 JUN 2015 08:25AM EST | DOI: 10.1002/hep.27950
AASLD commissions and provides financial support for formulation and production of Practice Guidelines by volunteer experts. Financial support from commercial entities or the pharmaceutical industry is not accepted for the development of AASLD practice guidelines. However, independent medical educational grants are permitted for the distribution of mobile download applications.
These evidence-based guidelines are developed and updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD strives to review and update its Practice Guidelines every five (5) years, as necessary. Users are cautioned that in the interim, scientific and medical developments may supercede or invalidate, in whole or in part, specific recommendations in any Guideline. A Guideline is considered to be "inactive" if it has not been updated by AASLD in at least five (5) years, and for this reason particular care must be exercised in placing reliance on an inactive Guideline.
Guidelines Development Policies
AASLD Practice Guidelines are copyright protected. One copy may be accessed for personal research, scientific, scholarly or informational purposes and may be transmitted to a third-party colleague in hard copy or electronically for similar use. One figure, table or brief excerpt less than 400 words may be used in one’s scientific, scholarly and educational work with appropriate credit. Permission is required to reproduce more than one figure, table, or section over 400 words or complete practice guidelines and position papers for systematic redistribution. Re-sale and posting AASLD practice guidelines on other websites are not allowed; however, linking to AASLD guidelines is permitted. Please contact adavisowino@aasld.org for assistance.
